WallStreetZenWallStreetZen

NASDAQ: CARA
Cara Therapeutics Inc Stock Ownership - Who owns Cara Therapeutics?

Insider buying vs selling

Have Cara Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Scott TerrillionSECY CHIEF COMPLIANCE G.C.2024-02-293,293$0.89
$2.93kSell
Joana GoncalvesCHIEF MEDICAL OFFICER2024-02-293,293$0.89
$2.93kSell
Christopher PosnerPRESIDENT AND CEO2024-02-295,834$0.89
$5.19kSell
Christopher PosnerPRESIDENT AND CEO2024-02-0835,575$0.53
$18.85kSell
Christopher PosnerPRESIDENT AND CEO2024-02-014,981$0.55
$2.74kSell
Christopher PosnerPresident and CEO2023-11-023,796$1.22
$4.63kSell
Christopher PosnerPresident and CEO2023-08-034,307$3.07
$13.22kSell
Joana GoncalvesChief Medical Officer2023-06-232,723$3.51
$9.56kSell
Frederique Phd MenzaghiChief Scientific OffSVP-RD2023-06-232,993$3.51
$10.51kSell
Scott TerrillionSecy Chief Compliance G.C.2023-06-232,483$3.51
$8.72kSell

1 of 2

CARA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CARA insiders and whales buy or sell their stock.

CARA Shareholders

What type of owners hold Cara Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Csl Ltd13.53%7,396,770$6.43MInsider
Vifor International Ltd13.53%7,396,770$6.43MInsider
Dean Slagel7.18%3,925,825$3.41MInsider
Rho Ventures Vi LP6.53%3,568,057$3.10MInsider
Blackrock Inc6.50%3,554,258$3.09MInstitution
Martin Vogelbaum5.81%3,177,769$2.76MInsider
Vanguard Group Inc4.81%2,631,067$2.29MInstitution
Disciplined Growth Investors Inc3.32%1,812,100$1.57MInstitution
Chescapmanager LLC3.21%1,752,112$1.52MInstitution
Charles Phd Moller2.88%1,576,404$1.37MInsider

1 of 3

CARA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CARA44.64%53.43%Net SellingNet Selling
OCUP1.23%98.77%Net BuyingNet Buying
APM0.85%40.28%
ACHL53.41%0.00%
INAB19.83%52.04%Net Buying

Cara Therapeutics Stock Ownership FAQ

Who owns Cara Therapeutics?

Cara Therapeutics (NASDAQ: CARA) is owned by 44.64% institutional shareholders, 53.43% Cara Therapeutics insiders, and 1.93% retail investors. Csl Ltd is the largest individual Cara Therapeutics shareholder, owning 7.40M shares representing 13.53% of the company. Csl Ltd's Cara Therapeutics shares are currently valued at $6.73M.

If you're new to stock investing, here's how to buy Cara Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.